BioCardia, Inc. — Form 8-K
Filed August 21, 2026 · analyzed by the 8-K Agent
8-K
▼ Likely negative
significance 92/100
What the filing says
On August 19, 2026, BioCardia received notice of failure to satisfy continued listing standards. The filing indicates Item 3.01 delisting notice but does not specify the reason, exchange, cure period, or any other details. At $9.7M market cap, delisting would be existential—eliminating public trading and likely access to capital markets.
Why this rating
Delisting is business-threatening for a micro-cap. Loss of public status materially impairs equity financing, market liquidity, and operational runway.
Extracted items
See more from August 21, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.